Nicholas A Saunders
4PUBLICATIONS
4CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (4)
Sort by Publication Date:
|Dec 23, 2020
Correction: HDAC7 is an actionable driver of therapeutic antibody resistance by macrophages from CLL patients.M Burgess, Y C E Chen, S Mapp
|Jul 26, 2020
HDAC7 is an actionable driver of therapeutic antibody resistance by macrophages from CLL patients.M Burgess, Y C E Chen, S Mapp
|Aug 24, 2019
Auranofin improves overall survival when combined with standard of care in a pilot study involving dogs with osteosarcoma.Liliana Endo-Munoz, Tristram C Bennett, Eleni Topkas
|Jun 29, 2018
Targeting the XPO1-dependent nuclear export of E2F7 reverses anthracycline resistance in head and neck squamous cell carcinomas.Natalia Saenz-Ponce, Rachael Pillay, Lilia Merida de Long
Pageof 1
